CoChat

Human metabolism and pharmacological profiling of protonitazepyne and metonitazepyne, two highly potent nitazenes: prediction of main metabolite activity based on µ-opioid receptor docking simulations

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Nitazenes have recently surfaced the illicit opioid market, causing numerous intoxications and fatalities. N -Pyrrolidino derivatives, protonitazepyne and metonitazepyne, have circulated since 2023 and have been involved in overdose intoxications. Their pharmacological properties remain largely unknown. However, pharmacokinetic/dynamic data are crucial for clinicians and toxicologists to manage intoxications and interpret legal cases. Protonitazepyne and metonitazepyne metabolism was assessed using human hepatocyte incubations and blood/urine from an intoxication case; samples were analyzed with liquid chromatography–high-resolution mass spectrometry and software-aided data mining. µ-(MOR), κ-(KOR), and δ-(DOR) opioid receptor activation was assessed using a GTP G i binding assay. MOR docking was simulated with UCSF Chimera and AutoDockSuite. Pharmacological relevance of major metabolites was predicted through in silico MOR docking. Major metabolites were produced through nitroreduction, pyrrolidine N -dealkylation, and oxidation to N -butanoic acid and O -dealkylation. Protonitazepyne and metonitazepyne potencies at MOR were 3.7 and 11.5 nmol L −1 , respectively; efficacies were 154 and 101%. Partial agonism and low potency were observed at KOR/DOR. In silico inhibition constants at MOR for protonitazepyne, 5-amino-protonitazepyne, metonitazepyne, and 5-amino-metonitazepyne were 0.68, 11.45, 1.98, and 2,050 nmol L −1 , respectively. Protonitazepyne and metonitazepyne are MOR-selective full agonists, with potencies about seven and two times higher than fentanyl. These nitazenes present significant health risks through central nervous system/respiratory depression. Their primary metabolites showed lower/marginal in silico MOR affinity, suggesting they might be pharmacologically active, albeit to a much lesser extent than the parent compounds. We propose 5-amino derivatives (blood) and N -butanoic acid derivatives (urine) as biomarkers for detecting consumption.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00204-025-04163-4

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 HRMS/MS spectra of metonitazepyne (A), and major metabolites A1 [5-amino-metonitazepyne (B)], A3 [O-desmethyl metonitazepyne glucuronide (C)], and A13 [N-butanoic acid metonitazene (D)], as well as their suggested fragmentation patterns. HRMS/MS spectra of protonitazepyne (E), and major metabolites B2 [O-desmethyl-protonitazepyne glucuronide (F)], B3 [5-amino-protonitazepyne (G)], and B16 [N-butanoic acid-protonitazene (H)], as well as their suggested fragmentation patterns. A3 = B2; Gluc, glucuronide
Fig. 1 HRMS/MS spectra of metonitazepyne (A), and major metabolites A1 [5-amino-metonitazepyne (B)], A3 [O-desmethyl metonitazepyne glucuronide (C)], and A13 [N-butanoic acid metonitazene (D)], as well as their suggested fragmentation patterns. HRMS/MS spectra of protonitazepyne (E), and major metabolites B2 [O-desmethyl-protonitazepyne glucuronide (F)], B3 [5-amino-protonitazepyne (G)], and B16 [N-butanoic acid-protonitazene (H)], as well as their suggested fragmentation patterns. A3 = B2; Gluc, glucuronideCC BY · PubMed Central
Fig. 2 Metonitazepyne and protonitazepyne μ-(MOR) (A), κ-(KOR) (B), and δ-(DOR) (C) opioid activation profiles (normalized to fentanyl, U-50488, and SNC-80 signal). Data are presented as mean ± SEM, n = 3; FRET, fluorescence resonance energy transfer
Fig. 2 Metonitazepyne and protonitazepyne μ-(MOR) (A), κ-(KOR) (B), and δ-(DOR) (C) opioid activation profiles (normalized to fentanyl, U-50488, and SNC-80 signal). Data are presented as mean ± SEM, n = 3; FRET, fluorescence resonance energy transferCC BY · PubMed Central
Fig. 3 Analysis of MOR–ligand complexes: metonitazepyne-MOR complex (A) and focus on the binding site (B) (initial and final poses in orange and light blue sticks, respectively); 5-amino-metonitazepyne-MOR complex (C) and focus on the binding site (D) (initial and final poses in pink and light blue sticks, respectively); protonitazepyne-MOR complex (E) and focus on the binding site (F) (initial and final poses in goldenrod and green sticks, respectively); and protonitazepyne-MOR complex (G) and focus on the binding site (H) (initial and final poses in salmon and navy blue sticks, respectively). Transmembrane helices have different colors, and the lateral movement of the helices during the molecular dynamics simulations are reported in light blue
Fig. 3 Analysis of MOR–ligand complexes: metonitazepyne-MOR complex (A) and focus on the binding site (B) (initial and final poses in orange and light blue sticks, respectively); 5-amino-metonitazepyne-MOR complex (C) and focus on the binding site (D) (initial and final poses in pink and light blue sticks, respectively); protonitazepyne-MOR complex (E) and focus on the binding site (F) (initial and final poses in goldenrod and green sticks, respectively); and protonitazepyne-MOR complex (G) and focus on the binding site (H) (initial and final poses in salmon and navy blue sticks, respectively). Transmembrane helices have different colors, and the lateral movement of the helices during the molecular dynamics simulations are reported in light blueCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. Berardinelli D, Taoussi O, Carlier J et al (2024) In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne). Clin Chem Lab Med 62:1580–1590. https://doi.org/10.1515/CCLM-2023-1360/DOWNLOADASSET/SUPPL/J_CCLM-2023-1360_SUPPL_001.DOCX · doi:10.1515/cclm-2023-1360/downloadasset/suppl/j_cclm-2023-1360_suppl_001.docx

Cited by

See all 5

Metadata

Authors
Berardinelli, D., Taoussi, O., Ovat, D. Y., Pichini, S., Pulver, B., Auwärter, V., Busardò, F. P., Basile, G., Laudadio, E., & Carlier, J.
Affiliations
  • Marche Polytechnic University (IT)
  • Ege University (TR)
  • Istituto Superiore di Sanità (IT)
  • University of Freiburg (DE)
Corresponding author
Busardò, Francesco Paolo
Venue
Archives of Toxicology
Published
2025-10-31
Volume
100
Issue
2
Pages
543-556
ISSN
  • 0340-5761 (ISSN-L)
  • 1432-0738
OpenAlex
W4415720996
Cited by
5
References
30
Citations by year
2026: 5
FWCI
2.55
Type
journal article
Language
en
Open access
Licence
Locations
  • Archives of Toxicology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
  • Università Politecnica delle Marche (Università Politecnica delle Marche) (submittedVersion, cc-by)
Funders
Università Politecnica delle Marche
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
nitazenes, opioid metabolites, mu-opioid receptor, kappa opioid receptor, delta opioid receptor, nitro group reduction, pharmacokinetics, hepatocyte incubation, GTPgammaS binding, receptor docking, biomarkers, respiratory depression
MeSH terms
Analgesics, Opioid, Humans, Pyrrolidines, Receptors, Opioid, mu, Hepatocytes, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human metabolism and pharmacological profiling of protonitazepyne and metonitazepyne, two highly potent nitazenes: prediction of main metabolite activity based on µ-opioid receptor docking simulations. https://app.cochat.ai/papers/10.1007/s00204-025-04163-4
The paper
Berardinelli, D., Taoussi, O., Ovat, D. Y., Pichini, S., Pulver, B., Auwärter, V., Busardò, F. P., Basile, G., Laudadio, E., & Carlier, J. (2026). Human metabolism and pharmacological profiling of protonitazepyne and metonitazepyne, two highly potent nitazenes: prediction of main metabolite activity based on µ-opioid receptor docking simulations. Archives of Toxicology. https://doi.org/10.1007/s00204-025-04163-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.